A Commitment Device for Medication Adherence Among HIV Patients

Completed · Not applicable

Conditions studied: Acquired Immunodeficiency Syndrome, HIV

In brief

We used a randomized trial design combined with a comparison to a non-randomized control group to study patients on appropriate antiretroviral therapy (ART) having virologic failure within a publicly-funded HIV clinic serving Atlanta, GA.

Key facts

Study ID

NCT01455740

Run by

National Bureau of Economic Research, Inc.

People needed

110

Starts

2011-10-01

Expected to finish

2014-10-01

Last updated by the study team

2017-12-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Attended the Grady Health System Infectious Disease Program (IDP)
• Most recent HIV-1 plasma RNA viral load (pVL) > 200 copies/mL; this value must have been measured within the prior 18 months and at least 6 months after starting the current ART regimen
• English-speaking

You may not qualify if…

• Using pillboxes
• Were planning to relocate
• Were enrolled in another trial

Where it is running

• Emory University Ponce Clinic — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.